AI Analysis

Log in to generate an AI summary for this stock.

Log in to generate a MOAT report for this stock.

Log in to generate an earnings report for this stock.

Log in to generate an operating leverage report for this stock.

Log in to generate a management report for this stock.

Log in to generate a valuation report for this stock.

Poolbeg Pharma PLC

8.98p +$5.08 (+130.38%)
LSE · 16 Sep 2026 08:50 UTC
Previous Close
8.7p
Day Range
8.6p8.98p
Year Range
3.3p9.2p
Market Cap
68.59M
AVG Volume
2.62M
Trailing/Forward PE
-9.66/-
PEG ratio
1.01
Dividend Yield
-
Next Earnings Date
2027-03-04
Primary Exchange
London Stock ExchangeUK
Net Income (GBP)
-4M-3M-2M-1M021 Q221 Q422 Q222 Q423 Q223 Q424 Q224 Q425 Q225 Q4
POLB.L Net Income (GBP) by quarter
PeriodNet Income (GBP)
25 Q4-3.52M
25 Q2-2.18M
24 Q4-3.53M
24 Q2-2.26M
23 Q4-2.12M
23 Q2-1.81M
22 Q4-3.08M
22 Q2-1.61M
21 Q4-1.17M
21 Q2-1.17M
Operating Income (GBP)
-4M-3M-2M-1M021 Q221 Q422 Q222 Q423 Q223 Q424 Q224 Q425 Q225 Q4
POLB.L Operating Income (GBP) by quarter
PeriodOperating Income (GBP)
25 Q4-3.86M
25 Q2-2.56M
24 Q4-3.84M
24 Q2-2.81M
23 Q4-2.79M
23 Q2-2.26M
22 Q4-3.38M
22 Q2-1.89M
21 Q4-1.17M
21 Q2-1.17M
EBITDA (GBP)
-4M-3M-2M-1M021 Q221 Q422 Q222 Q423 Q223 Q424 Q224 Q425 Q225 Q4
POLB.L EBITDA (GBP) by quarter
PeriodEBITDA (GBP)
25 Q4-3.83M
25 Q2-2.21M
24 Q4-3.48M
24 Q2-2.27M
23 Q4-2.68M
23 Q2-1.8M
22 Q4-3.06M
22 Q2-1.69M
21 Q4-1.16M
21 Q2-1.16M
Cash Flows (GBP)
-3M-2M-1M021 Q221 Q422 Q222 Q423 Q223 Q424 Q224 Q425 Q225 Q4
POLB.L Cash Flows (GBP) by quarter
PeriodCash Flows (GBP)
25 Q4-2.16M
25 Q2-2.35M
24 Q4-2.38M
24 Q2-2.26K
23 Q4-1.95M
23 Q2-2.07M
22 Q4-2.7M
22 Q2-2.06M
21 Q4-1.11M
21 Q2-1.11M
EPS (GBP)
-8-6-4-2021 Q221 Q422 Q222 Q423 Q223 Q424 Q224 Q425 Q225 Q4
POLB.L EPS (GBP) by quarter
PeriodEPS (GBP)
25 Q4-0.01
25 Q2-0
24 Q4-0.01
24 Q2-4.52
23 Q4-4.28
23 Q2-3.62
22 Q4-6.16
22 Q2-3.21
21 Q4-2.33
21 Q2-2.33
Expenses (GBP)
-4M-2M02M4MR&DSG&ACapex21 Q221 Q422 Q222 Q423 Q223 Q424 Q224 Q425 Q225 Q4
POLB.L Expenses (GBP) by quarter
PeriodExpenses (GBP)
25 Q41.67M
25 Q22.53M
24 Q43.83M
24 Q21.41K
23 Q42.89M
23 Q22.31M
22 Q43.58M
22 Q22.26M
21 Q41.26M
21 Q21.26M
Cash & Debt (GBP)
010M20M30M21 Q221 Q422 Q222 Q423 Q223 Q424 Q224 Q425 Q225 Q4
POLB.L Cash & Debt (GBP) by quarter
PeriodCash & Debt (GBP)
25 Q47.71M
25 Q29.96M
24 Q47.82M
24 Q210.06M
23 Q412.17M
23 Q214.12M
22 Q416.19M
22 Q218.89M
21 Q420.95M
21 Q223.23M
Debt ratios
012322 Q423 Q223 Q424 Q224 Q425 Q225 Q4
POLB.L Debt ratios by quarter
PeriodDebt ratios
25 Q40.65
25 Q20.94
24 Q40.76
24 Q21.03
23 Q41.32
23 Q21.83
22 Q42.29
Return on Capital
-60%-40%-20%0%21 Q221 Q422 Q222 Q423 Q223 Q424 Q224 Q425 Q225 Q4
POLB.L Return on Capital by quarter
PeriodReturn on Capital
25 Q4-40.89%
25 Q2-18.25%
24 Q4-38.09%
24 Q2-18.14%
23 Q4-14.68%
23 Q2-10.94%
22 Q4-16.8%
22 Q2-7.58%
21 Q4-5.17%
21 Q2-4.79%
Shares Outstanding
0200M400M600M800M21 Q221 Q422 Q222 Q423 Q223 Q424 Q224 Q425 Q225 Q4
POLB.L Shares Outstanding by quarter
PeriodShares Outstanding
25 Q4703.4M
25 Q2506.54M
24 Q4497.46M
24 Q2500M
23 Q4492.79M
23 Q2500M
22 Q4500M
22 Q2500M
21 Q4500M
21 Q2500M
Book Value Per Share (GBP)
00.020.040.0621 Q221 Q422 Q222 Q423 Q223 Q424 Q224 Q425 Q225 Q4
POLB.L Book Value Per Share (GBP) by quarter
PeriodBook Value Per Share (GBP)
25 Q40.01
25 Q20.02
24 Q40.02
24 Q20.02
23 Q40.03
23 Q20.03
22 Q40.04
22 Q20.04
21 Q40.05
21 Q20.05
Total Assets (GBP)
010M20M30M21 Q221 Q422 Q222 Q423 Q223 Q424 Q224 Q425 Q225 Q4
POLB.L Total Assets (GBP) by quarter
PeriodTotal Assets (GBP)
25 Q49.94M
25 Q212.36M
24 Q410.25M
24 Q213.01M
23 Q415.43M
23 Q217.07M
22 Q419.29M
22 Q222.01M
21 Q423.02M
21 Q224.74M
Poolbeg Pharma PLC
POLB.L
Stockpicker

Video analysis: POLB.L

All videos

No video analysis for this stock yet. Request one from our team.

Your email is used only to follow up on this request. We do not add you to marketing lists. Privacy Policy

Similar companies

Disclaimer: The historical data presented on this platform is provided by Financial Modeling Prep. Stock Picker is a platform for informational purposes only and does not provide financial advice. Users are encouraged to conduct their own research and consult with a qualified financial advisor before making investment decisions.